Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale

PURPOSE: The platinum chemotherapy agents cisplatin and carboplatin are widely used in the treatment of adult and pediatric cancers. Cisplatin causes hearing loss in at least 60% of pediatric patients. Reducing cisplatin and high-dose carboplatin ototoxicity without reducing efficacy is important. P...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Brock, Penelope R., Knight, Kristin R., Freyer, David R., Campbell, Kathleen C.M., Steyger, Peter S., Blakley, Brian W., Rassekh, Shahrad R., Chang, Kay W., Fligor, Brian J., Rajput, Kaukab, Sullivan, Michael, Neuwelt, Edward A.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2012
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3675696/
https://ncbi.nlm.nih.gov/pubmed/22547603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.39.1110
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires